Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?

Alessandro Inno¹, Anna Stagno^{1

2}, Stefania Gori¹

Affiliations

¹ Medical Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy.
² Medical Oncology Section, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.

Editorial

Alessandro Inno et al. Transl Lung Cancer Res. 2018 Dec.

. 2018 Dec;7(Suppl 4):S341-S345.

doi: 10.21037/tlcr.2018.11.06.

Alessandro Inno¹, Anna Stagno^{1

2}, Stefania Gori¹

¹ Medical Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy.
² Medical Oncology Section, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, de Groot P, Sulman EP, Wistuba II, Chen A, Fleisher M, Heymach JV, Kris MG, Rudin CM, Byers LA. Pietanza MC, et al. J Clin Oncol. 2018 Aug 10;36(23):2386-2394. doi: 10.1200/JCO.2018.77.7672. Epub 2018 Jun 15. J Clin Oncol. 2018. PMID: 29906251 Free PMC article. Clinical Trial.

1. Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer 2015;121:664-72. 10.1002/cncr.29098 - DOI - PMC - PubMed
1. Niell HB, Herndon JE, 2nd, Miller AA, et al. Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. J Clin Oncol 2005;23:3752-9. 10.1200/JCO.2005.09.071 - DOI - PubMed
1. Rossi A, Di Maio M, Chiodini P, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012;30:1692-8. 10.1200/JCO.2011.40.4905 - DOI - PubMed
1. Hanna N, Bunn PA, Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006;24:2038-43. 10.1200/JCO.2005.04.8595 - DOI - PubMed
1. Horita N, Yamamoto M, Sato T, et al. Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients. Sci Rep 2015;5:15437. 10.1038/srep15437 - DOI - PMC - PubMed